dehydroepiandrosterone has been researched along with Muscle Weakness in 5 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshihara, T | 1 |
| Ozaki, H | 1 |
| Nakagata, T | 1 |
| Natsume, T | 1 |
| Kitada, T | 1 |
| Ishihara, Y | 1 |
| Sawada, S | 1 |
| Ishibashi, M | 1 |
| Kobayashi, H | 1 |
| Machida, S | 1 |
| Naito, H | 1 |
| Fragala, MS | 1 |
| Dam, TT | 1 |
| Barber, V | 1 |
| Judge, JO | 1 |
| Studenski, SA | 1 |
| Cawthon, PM | 1 |
| McLean, RR | 1 |
| Harris, TB | 1 |
| Ferrucci, L | 1 |
| Guralnik, JM | 1 |
| Kiel, DP | 1 |
| Kritchevsky, SB | 1 |
| Shardell, MD | 1 |
| Vassileva, MT | 1 |
| Kenny, AM | 2 |
| Voznesensky, M | 1 |
| Walsh, S | 1 |
| Dauser, D | 1 |
| Brindisi, J | 1 |
| de los Reyes, AD | 1 |
| Bagchi, D | 1 |
| Preuss, HG | 1 |
| Payne, JK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients With Advanced Heart Failure[NCT03574662] | 1 participants (Actual) | Interventional | 2018-05-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dehydroepiandrosterone and Muscle Weakness
| Article | Year |
|---|---|
Overview of resistance training, diet, hormone replacement and nutritional supplements on age-related sarcopenia--a minireview.
Topics: Adult; Aged; Aging; Amino Acids, Branched-Chain; Dehydroepiandrosterone; Dietary Proteins; Exercise; | 2003 |
The trajectory of biomarkers in symptom management for older adults with cancer.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aging; Anxiety; Biomarkers; Biomarkers, Tumor; Cy | 2006 |
3 other studies available for dehydroepiandrosterone and Muscle Weakness
| Article | Year |
|---|---|
Association between locomotive syndrome and blood parameters in Japanese middle-aged and elderly individuals: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biomarkers; Cross-Sectional Studies; Dehydroepiandrost | 2019 |
Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia project.
Topics: Absorptiometry, Photon; Adjuvants, Immunologic; Aged; Body Composition; Bone Density Conservation Ag | 2015 |
The association between dehydroepiandosterone and frailty in older men and women.
Topics: Aged; Aged, 80 and over; Aging; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Frail Elder | 2009 |